ARQUENNES PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ARQUENNES PHARMA
Largest movements
- Stocks and contracts -€103,837
down €103,837 (-37.1%), from €280,044 to €176,207
- Cash -€19,963
down €19,963 (-9.2%), from €217,166 to €197,203
mainly Contributions, distributions and other (-€130,000) and Debts after one year (-€82,689)
- Receivables within one year +€15,519
up €15,519 (+12.9%), from €120,452 to €135,971
of which Other amounts receivable: +€14,924
- Tangible fixed assets +€11,200
up €11,200 (+5.8%), from €191,837 to €203,037
of which Furniture and vehicles: +€23,362
- Debts after one year -€82,689
down €82,689 (-26.7%), from €309,912 to €227,223
of which Other amounts payable: -€56,022
- Accrued charges and deferred income -€18,233
no longer reported in 2025 (was €18,233)
- Tax, wage and social debts +€10,217
up €10,217 (+6.2%), from €163,559 to €173,776
of which Remuneration and social security: +€6,359
- Other debts -€8,839
no longer reported in 2025 (was €8,839)
- Gross operating margin -€21,044
down €21,044 (-4.4%), from €483,106 to €462,062
- Depreciation -€20,275
down €20,275 (-61.8%), from €32,833 to €12,558
- Staff costs -€7,186
down €7,186 (-2.4%), from €294,606 to €287,420
- Financial charges -€4,836
down €4,836 (-17.5%), from €27,570 to €22,734
of which Financial charges: -€4,730
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €809,649 | €712,567 | -€97,081 | -12.0% |
| Fixed assets | 21/28 | €191,987 | €203,187 | +€11,200 | +5.8% |
| Tangible fixed assets | 22/27 | €191,837 | €203,037 | +€11,200 | +5.8% |
| Land and buildings | 22 | €176,370 | €165,347 | -€11,023 | -6.2% |
| Furniture and vehicles | 24 | - | €23,362 | +€23,362 | |
| Other tangible fixed assets | 26 | €15,466 | €14,328 | -€1,139 | -7.4% |
| Financial fixed assets | 28 | €150 | €150 | = | 0.0% |
| Current assets | 29/58 | €617,662 | €509,381 | -€108,281 | -17.5% |
| Stocks and contracts in progress | 3 | €280,044 | €176,207 | -€103,837 | -37.1% |
| Stocks | 30/36 | €280,044 | €176,207 | -€103,837 | -37.1% |
| Amounts receivable within one year | 40/41 | €120,452 | €135,971 | +€15,519 | +12.9% |
| Trade receivables | 40 | €4,853 | €5,448 | +€595 | +12.3% |
| Other amounts receivable | 41 | €115,599 | €130,523 | +€14,924 | +12.9% |
| Cash at bank and in hand | 54/58 | €217,166 | €197,203 | -€19,963 | -9.2% |
| Total equity and liabilities | 10/49 | €809,649 | €712,567 | -€97,081 | -12.0% |
| Equity | 10/15 | €236,029 | €238,406 | +€2,377 | +1.0% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €64,611 | €64,611 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €12,218 | €12,218 | = | 0.0% |
| Distributable reserves | 133 | €46,193 | €46,193 | = | 0.0% |
| Profit (loss) carried forward | 14 | €109,418 | €111,795 | +€2,377 | +2.2% |
| Amounts payable | 17/49 | €573,620 | €474,162 | -€99,458 | -17.3% |
| Amounts payable after more than one year | 17 | €309,912 | €227,223 | -€82,689 | -26.7% |
| Financial debts | 170/4 | €82,223 | €55,556 | -€26,667 | -32.4% |
| Other amounts payable | 178/9 | €227,690 | €171,667 | -€56,022 | -24.6% |
| Amounts payable within one year | 42/48 | €245,475 | €246,939 | +€1,464 | +0.6% |
| Current portion of amounts payable after more than one year | 42 | €26,667 | €26,667 | = | 0.0% |
| Trade debts | 44 | €46,411 | €46,496 | +€86 | +0.2% |
| Suppliers | 440/4 | €46,411 | €46,496 | +€86 | +0.2% |
| Taxes, remuneration and social security | 45 | €163,559 | €173,776 | +€10,217 | +6.2% |
| Taxes | 450/3 | €2,747 | €6,604 | +€3,857 | +140.4% |
| Remuneration and social security | 454/9 | €160,812 | €167,172 | +€6,359 | +4.0% |
| Other amounts payable | 47/48 | €8,839 | - | -€8,839 | |
| Accrued charges and deferred income | 492/3 | €18,233 | - | -€18,233 | |
| Remuneration, social security and pensions | 62 | €294,606 | €287,420 | -€7,186 | -2.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €32,833 | €12,558 | -€20,275 | -61.8% |
| Other operating charges | 640/8 | €3,844 | €4,149 | +€305 | +7.9% |
| Gross operating margin | 9900 | €483,106 | €462,062 | -€21,044 | -4.4% |
| Operating profit (loss) | 9901 | €151,823 | €157,935 | +€6,112 | +4.0% |
| Financial income | 75/76B | €204 | €0 | -€204 | -99.8% |
| Recurring financial income | 75 | €22 | €0 | -€21 | -98.4% |
| Non-recurring financial income | 76B | €182 | - | -€182 | |
| Financial charges | 65/66B | €27,570 | €22,734 | -€4,836 | -17.5% |
| Recurring financial charges | 65 | €27,464 | €22,734 | -€4,730 | -17.2% |
| Non-recurring financial charges | 66B | €106 | - | -€106 | |
| Profit (loss) for the period before taxes | 9903 | €124,457 | €135,201 | +€10,744 | +8.6% |
| Income taxes | 67/77 | €2,627 | €2,824 | +€198 | +7.5% |
| Profit (loss) for the period | 9904 | €121,830 | €132,377 | +€10,547 | +8.7% |
| Profit (loss) for the period to be appropriated | 9905 | €121,830 | €132,377 | +€10,547 | +8.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.